Watchlist Price Alert

Emergent BioSolutions Inc... (EBS)

NYSE: EBS · Real-Time Price · USD

6.29

0.05 (0.80%)

At close: Jun 17, 2025, 3:34 PM

Emergent BioSolutions Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	99.5M	111.7M	642.6M	576.1M	621.3M	167.8M	112.2M	178.29M	271.51M
Short-Term Investments	n/a	n/a	8.5M	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	18.9M	178.1M	191.3M	57.3M	113.4M	76.9M	13.7M	6.05M	2.48M
Receivables	154.5M	191M	159.2M	278.9M	230.9M	270.7M	262.5M	146.1M	148.47M
Inventory	311.7M	328.9M	351.8M	350.8M	307M	222.5M	205.8M	142.81M	74M
Other Current Assets	33M	47.9M	57.9M	100K	36.7M	200K	200K	1M	n/a
Total Current Assets	598.7M	679.5M	1.21B	1.27B	1.2B	686.2M	620.8M	485.39M	510.22M
Property-Plant & Equipment	270.6M	399M	817.6M	800.1M	644.1M	542.3M	510.2M	407.21M	376.45M
Goodwill & Intangibles	501.5M	566.6M	947M	829.5M	929.8M	1.01B	1.07B	168.73M	74.87M
Total Long-Term Assets	791M	1.14B	1.96B	1.69B	1.69B	1.64B	1.61B	584.82M	459.89M
Total Assets	1.39B	1.82B	3.17B	2.96B	2.88B	2.33B	2.23B	1.07B	970.11M
Account Payables	60.9M	112.2M	103.5M	128.9M	136.1M	94.8M	80.7M	41.8M	34.65M
Deferred Revenue	n/a	n/a	26.4M	140.4M	131.5M	101.9M	10.6M	13.23M	7.04M
Short-Term Debt	n/a	413.7M	957.3M	31.6M	33.8M	12.9M	10.1M	n/a	20M
Other Current Liabilities	83.8M	106.8M	133.2M	161.8M	167.7M	69.1M	36.3M	7.2M	9.63M
Total Current Liabilities	162.4M	651.3M	1.23B	373.8M	384.5M	216.3M	200.4M	100.07M	105.86M
Long-Term Debt	663.7M	446.5M	448.5M	809.4M	841M	798.4M	784.5M	13.5M	248.09M
Other Long-Term Liabilities	39.1M	76.1M	26.7M	40.6M	74.2M	52.5M	103.6M	44.3M	11.52M
Total Long-Term Liabilities	744.5M	522.6M	553.7M	966.2M	1.05B	1.02B	1.02B	57.79M	268.05M
Total Liabilities	906.9M	1.17B	1.78B	1.34B	1.44B	1.24B	1.22B	157.86M	373.91M
Total Debt	663.7M	860.2M	1.41B	841M	874.8M	811.3M	794.6M	13.46M	268.09M
Common Stock	100K	100K	100K	100K	100K	100K	100K	50K	41K
Retained Earnings	-212.4M	-21.8M	734M	957.8M	726.9M	421.8M	367.3M	337.07M	254.48M
Comprehensive Income	-5.2M	-5.7M	3.1M	-16.1M	-25.3M	-9.9M	-5.5M	-3.7M	-4.33M
Shareholders Equity	482.8M	649.3M	1.38B	1.62B	1.45B	1.09B	1.01B	912.35M	596.21M
Total Investments	n/a	n/a	8.5M	n/a	n/a	n/a	n/a	n/a	n/a